Stock Price Quote

LAURUS LABS LTD.

NSE : LAURUSLABSBSE : 540222ISIN CODE : INE947Q01028Industry : Pharmaceuticals & DrugsHouse : Private
BSE370.650.55 (+0.15 %)
PREV CLOSE ( ) 370.10
OPEN PRICE ( ) 371.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 85441
TODAY'S LOW / HIGH ( )366.65 374.70
52 WK LOW / HIGH ( )61.9 379.35
NSE370.550.4 (+0.11 %)
PREV CLOSE( ) 370.15
OPEN PRICE ( ) 371.50
BID PRICE (QTY) 370.55 (4627)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 2221834
TODAY'S LOW / HIGH( ) 366.85 375.00
52 WK LOW / HIGH ( )59 379.75
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 19-09 2005
Management Info
Malempati Venugopala Rao - Chairman - Managing Director
Registered Office

Address Plot No.21, J N Pharma City,Parawada, ,
Vishakhapatnam,
Andhra Pradesh-531021

Phone 0891 3061222

Email nagaraj.a@lauruslabs.com

Website www.lauruslabs.com

Registrars Details
K FIN Technologies Pvt Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE

NEWS

21Jan Laurus Labs acquires 72.55% stake in R
Laurus Labs has completed acquisition of 72.55% stake in Richcore Lifesc..
21Jan Laurus Labs, SpiceJet and Infosys to s
Laurus Labs has completed acquisition of 72.55% stake in Richcore Lifesc..
21Jan Laurus Labs gains on acquiring 72.55%
Laurus Labs is currently trading at Rs. 375.75, up by 3.80 points or 1.0..
19Jan Laurus Labs informs about board meeting
Laurus Labs has informed that the meeting of the Board of Directors of t..
19Jan Board Meeting Intimation for Q3 FY 20
Laurus Labs Ltdhas informed BSE that the meeting of the Board of Directo..

Financials

in Millions
QTR Sep 20 ANNUAL 20
Net Profit2375.92670.47
Gross Profit 3124.9 3044.82
Operating Profit 3746.55760.46
Net Sales 1127327973.35

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Gland Pharma (BSE)
peergroup  2282.90 (3.53%)
M.Cap ( in Cr)37275.84
Solara Active Pharma (BSE)
peergroup  1344.25 (4.17%)
M.Cap ( in Cr)4827.17
RPG Life Sciences (BSE)
peergroup  444.50 (6.54%)
M.Cap ( in Cr)735.16
Aurobindo Pharma (BSE)
peergroup  923.65 (2.33%)
M.Cap ( in Cr)54120.22
Orchid Pharma (BSE)
peergroup  274.80 (4.99%)
M.Cap ( in Cr)1121.63

Shareholding Pattern

NON-INSTITUTION 47.27%
PROMOTERS 28.73%
MUTUAL FUNDS/UTI 2.41%
FII 19.92%
FI/BANKS/INSURANCE 0%
GOVERNMENT 0%

About Laurus Labs Ltd.

Laurus Labs Ltd. was incorporated in the year 2005. Its today's share price is 370.65. Its current market capitalisation stands at Rs 19889.17 Cr. In the latest quarter, company has reported Gross Sales of Rs. 27973.35 Cr and Total Income of Rs.28031.49 Cr. The company's management includes Lakshmana Rao CV, Ravindranath Kancherla, Rajesh Koshy Chandy, Aruna Bhinge, Chandrakanth Chereddi, Venkata Ravi Kumar Vantaram, Malempati Venugopala Rao.

It is listed on the BSE with a BSE Code of 540222 , NSE with an NSE Symbol of LAURUSLABS and ISIN of INE947Q01028. It's Registered office is at Plot No.21, J N Pharma City,Parawada, Vishakhapatnam-531021, Andhra Pradesh. Their Registrars are ACC Ltd. It's auditors are Deloitte Haskins & Sells LLP, SR Batliboi & Associates LLP

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)